Publications Office of the EU
Poland-Łódź: Antineoplastic and immunomodulating agents - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates text translated automatically in your browsing language

Poland-Łódź: Antineoplastic and immunomodulating agents

Overview
  • Published
    05/12/2018
  • Deadline
    18/12/2018
  • Opening of tenders
    18/12/2018
  • Awarded
    19/12/2018
  • Today
    06/08/2026
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
Instytut "Centrum Zdrowia Matki Polki"
Place of performance
NUTS code: PL711 Miasto Łódź
Location of buyer
NUTS code: PL711 Miasto Łódź
Business sector (Main CPV)
33652000 33652000
Total estimated contract value (excluding VAT)
278,317.50 PLN
Total final contract value (excluding VAT)
876,376.50 PLN
Number of lots
2
Procedure details
Tender reference number
ZP/130/2018
Description

The subject-matter of the contract is the supply of trastuzumabum to the Institute “CZMP”.

Submission Method
Electronic via:
https://iczmp.ezamawiajacy.pl
Tenders may be submitted
Submission for all lots
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
18/12/2018 10:15
Place of performance
PL711 Miasto Łódź
CPV code

33652000 - 33652000

Lots (2)
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.